Journal of Vaccine & Immunotechnology

Editorial Board

Editor-in-Chief
Dr. Sherven Sharma
Dr. Sherven Sharma

is a Professor of Medicine at David Geffen School of Medicine, University of California, Los Angeles, USA. His research focuses on inflammation, immunological targeting of cancer & investigating the biological characteristics of cancer for the development of novel therapeutics.

Dr. Dario Marchetti
Dr. Dario Marchetti

is a Professor in the Department of Pathology & Immunology with a joint faculty appointment in the Department of Molecular & Cellular Biology at Baylor College of Medicine in Houston. He also serves on grant reviewing panels of the NIH of USA and Italy, the Department of Defense of the United States and acts as invited grant reviewer for several other agencies devoted to oncology research.

Dr. Igor S. Lukashevich
Dr. Igor S. Lukashevich

is a Professor of Pharmacology and Toxicology; Microbiology and Immunology at University of Louisville, USA. His long-standing research interest is molecular biology, pathogenesis, treatment and prevention of viral hemorrhagic fevers and encephalitides caused by highly pathogenic viruses. His recent interest is the pre-clinical development of emerging vaccine products.

Dr. Hisham E. Ragab
Dr. Hisham E. Ragab

is a Professor of Forensic Medicine & Toxicology, Alexandria Fcculty of Medicine, Egypt and Instructor of Forensic science Program, University of Toronto Mississauga, Canada. He is awarded with the title “Scientist of the Year 2004” presented by International Biographical Centre, Cambridge, England for the contributions to the field of Forensic Sciences.

Dr. Zafar K. Khan
Dr. Zafar K. Khan

is a Professor in the Department of Microbiology & Immunology at Drexel University College of Medicine, USA. His research efforts primarily focus on defining the mechanism of virus-induced neuroinflammation and demyelination in the central and peripheral nervous system in order to identify potential diagnostic markers and targets for therapeutic intervention.

Dr. Noah Isakov
Dr. Noah Isakov

is a Professor of Cancer Immunobiology in The Shraga Segal Department of Microbiology, Immunology and Genetics, The Goldman Medical School, Ben Gurion University of the Negev, Israel. His major interest is in signal transduction mechanisms in normal and transformed cells, predominantly in the immune system.

Dr. Kamil Kuca
Dr. Kamil Kuca

is a Professor, Faculty of Military Health Sciences, University of Defense, Czech Republic. His research interests are toxicology, pharmacology, drug desing, nerve agent poisonings, CBRN, IT, vaccine adjuvans, technology transfer, pharmacoeconomy, chemical and biological terrorism.

Dr. Daniel Dennis Taub
Dr. Daniel Dennis Taub

is the Director and Senior Scientist, Center for Translational Studies, Department of Veteran Affairs, USA. His research interest includes evaluation of cancer and microbial vaccines in the elderly immunosuppressed, immunotherapy strategies, aging-immune evaluations, hormone infusion studies, inflammation and Alzheimer’s disease.

Dr. J. Hyun Park
Dr. J. Hyun Park

is Chief of the Cytokine Biology Unit, Experimental Immunology Branch, National Cancer Institute, National Institutes of Health. He received his PhD from the University of Wuerzburg in Germany on the role of cytokine signaling during T cell development. His current research is focused on the role of cytokine receptor expression and regulation during T cell homeostasis and activation.

Dr. Namrata Chhabra
Dr. Namrata Chhabra

is a Professor and Head in Department of Biochemistry at S.S.R Medical College, Mauritius. She credits a multitude of research publications, she is also faculty, editor, reviewer, member advisory board of peer reviewed journals. Her research interests are based on the risk prediction and preventive aspects of Ischemic heart disease, diabetes mellitus, obesity and cancers.

Dr. Mahendra Pal
Dr. Mahendra Pal

is an Ex-Professor of Veterinary Public Health, Addis Ababa University, Ethiopia. He elucidated the etiologic role of Cryptococcus neoformans in mastitis of goat and buffalo, Aspergillus fumigatus in rhinitis of camel, & mule, & Trichopphyton verrucosum in dermatitis of deer & developed Pal sunflower seed medium, APRM agar, PHOL stain & Narayan stain for the study of fungi.

Dr. Margaret Bynoe
Dr. Margaret Bynoe

is an Associate Professor in the Department of Microbiology and Immunology at Cornell University, USA. Her research goal is to understand how the immune system works and to elucidate the cellular and molecular basis of immune defects/dysfunctions that manifest in autoimmune diseases or failure of the immune system to eradicate cancer.

Dr. Yanjin Zhang
Dr. Yanjin Zhang

is an Associate Professor in the University of Maryland, College Park, MD, USA. His research interests are on molecular virology and viral pathogenesis and his current projects are on elucidating virus-cell interactions of hepatitis E virus and porcine reproductive and respiratory syndrome virus. He is interested in vaccine development.

Dr. Takeshi Yamada
Dr. Takeshi Yamada

is an Associate Professor in the Department of Infections & Host Defenses, Ehime University Graduate School of Medicine. His reaearch focuses on Infectious diseases & immunology. He completed his Ph.D. in the Institute of Medical Science at the University of Tokyo in Japan. Dr. Yamada’s current research is focused on lymphoid proliferation and maintenance of hematopoietic stem cells.

Dr. Guey Chuen Perng
Dr. Guey Chuen Perng

is an Associate Professor, Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Taiwan, with a joint appointment with Emory Vaccine Center. He also worked at AFRIMS, an affiliated research institute to US Military, Bangkok, Thailand, as Director of Arbovirology division. His research focuses on Pathogenesis of virus infections.

Dr. Luis Ulloa
Dr. Luis Ulloa

is an Associate Professor in the Department of Surgery at New Jersey Medical School, Rutgers University, USA. His research focuses on the anti-inflammatory potential of the nervous system to control systemic inflammation and organ damage in critical care including trauma, hemorrhage, infectious diseases and inflammatory disorders.

Dr. Zhiwei Hu
Dr. Zhiwei Hu

is an Associate Professor of The Ohio State University College of Medicine, USA. His research interests focus on developing and translating novel therapeutics by dual targeting of tumor cells and tumor neovasculature for the treatment of cancer.

Dr. Hanping Feng
Dr. Hanping Feng

is an Associate Professor at the Department of Microbial Pathogenesis with a secondary appointment at the Department of Microbiology and Immunology at the University of Maryland Baltimore, USA. His research focus is on understanding the pathogenesis of Clostridium difficile infection and developing vaccines and therapeutic antibodies against the disease.

Dr. Xianzhong Yu
Dr. Xianzhong Yu

is an associate professor in the Department of Biological Sciences, Clemson University, USA. His long-standing research interest is cancer gene therapy, cancer immunotherapy, and transgenic animal models. His current research interest is the development of dendritic tumor vaccines and chimeric antigen receptors.

Dr. Qingsheng Li
Dr. Qingsheng Li

is an Associate Professor at School of Biological Sciences, University of Nebraska-Lincoln, USA. His research focuses on studying HIV-1 pathogenesis, transmission and prevention using single cell in situ analyses and in vivo SIV-rhesus macaque and humanized-BLT (bone marrow liver and thymus) mouse models of HIV-1 infection.

Dr. Sam Kung
Dr. Sam Kung

is an Associate Professor in the Department of Immunology at University of Manitoba, Canada. He is currently the project leader of the CFI-funded Laboratory of Innate Immunobiology. He is interested in identifying factors that regulate differentiation and functions of natural killer cell, dendritic cells.

Dr. Martin Guimond
Dr. Martin Guimond

is an Assistant Professor and Head of the Lymphocyte Homeostasis and T-cell Regeneration Lab in the Department of Microbiology-Immunology at the University of Montreal, Canada. Research in his lab focuses on understanding how naïve T cells are regenerated following lymphopenia in order to improve their recovery and later increase the efficacy of immunotherapy.

Dr. Wail M. Hassan
Dr. Wail M. Hassan

is an Assistant professor in the Department of Biomedical Sciences at the University of Wisconsin– Milwaukee, USA. His research focuses on anti-HIV immune responses, where he is developing computational methods for outcome prediction in primate lentiviral infections based on quantitative immunological parameters, and the molecular pathogenesis of Alzheimer’s disease.

Dr. Prachi P. Singh
Dr. Prachi P. Singh

is a Research Assistant Professor in the Department of Biological Sciences and a member of the Eck Institute of Global Health at the University of Notre Dame, USA. Her research focuses on dissecting the cellular and molecular mechanisms involved in host pathogen interaction that are critical to successful immune response against infection.

Dr. Inaya Hajj Hussein
Dr. Inaya Hajj Hussein

is an Assistant Professor in the Department of Biomedical Sciences at the Oakland University William Beaumont School of Medicine, USA. Her research interests include basic and applied medical research focusing on Inflammatory Bowel Disease and Wound Healing.

Dr. Kang Chen
Dr. Kang Chen

is an Assistant Professor in the Department of Obstetrics and Gynecology at Wayne State University and the Perinatology Research Branch of Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH). His laboratory studies the immunology of reproduction and mucosal immunity of the reproductive tract.

Dr. Lixin Zhang
Dr. Lixin Zhang

is an Assistant Professor in the Department of Pathology and Immunology at Baylor College of Medicine.His research interests are; Discovery and development of new biomarkers for cancer early detection and metastasis prediction, Isolation and identification of circulating tumor cells, microRNA, DNA and protein which provides information for clinical therapeutics.

Jared D. Evans
Jared D. Evans

is an Assistant Professor at the University of Pittsburgh. He obtained his B.S. in Biology at The College of New Jersey. He earned his Ph.D. in Molecular Microbiology at Stony Brook University with Dr. Patrick Hearing. Dr. Evans was a post-doctoral fellow at The Salk Institute for Biological Sciences with Dr. John A.T. Young and Fox Chase Cancer Center with Dr. Christoph Seeger.

Dr. Feng Feng
Dr. Feng Feng

is an Assistant Professor in the Microbiology Department at Boston Univesity School of Medicine, USA. His overall goal is to develop computational tools to aid in the development of vaccine adjuvants. He is also working to develop statistical models/tools to understand the immune responses/events occurring after the adjuvant challenges.

Dr. Manoj Kumar Raman Unni Nair
Dr. Manoj Kumar Raman Unni Nair

is a Research Assistant Professor in the Department of Microbiology and Immunology at New York Medical College, USA. He is a Molecular virologist. His research focuses on viral vaccine development, viral diagnostics, viral genomics, and reverse genetics.

Dr. Upal Roy
Dr. Upal Roy

is an Assistant Professor of Immunology, Florida International University, USA. His research involves chronic immunological, pathological effect of anti-HIV drugs in humanized mouse model at different end organ level. His long term goal is to reduce the HIV associated dementia through molecular understanding of neuroAIDS and find some logical treatment to prevent disease progression?.

Dr. Sudheesh Pilakka-Kanthikeel
Dr. Sudheesh Pilakka-Kanthikeel

is an Assistant Professor in the Department of Immunology, at Florida International University, USA. He research focuses on HIV neuropathogenesis in drug abuse populations and nanomedicine approach for drug delivery to central nervous system for HIV treatment and microRNA regulation in HIV.

Dr. Brian Lawson
Dr. Brian Lawson

is an Assistant Professor, Department of Immunology & Microbial Science, The Scripps Research Institute. He is also serving as a Principal Investigator at California Institute of Biomedical Research. His research focuses on T cell activation and autoimmune-mediated neuroinflammation, Transmethylation in immunity and autoimmunity & Stem cell based approach to demyelinating diseases.

Dr. Han Dai
Dr. Han Dai

is a Manager in GlaxoSmithKline. His research interests include Drug Discovery, Drug Development, Immunology & Inflammation, Vaccine, Biophysics, and Structural Biology. He is an expert in structure based drug design, fragment-based drug discovery, drug/target interaction characterization and computational modeling.

Dr. Weiguo Cui
Dr. Weiguo Cui

is an Associate Investigator, Blood Center of Wisconsin, USA. His research focuses on T cell response during viral infection, molecular mechanisms of CD 4 & CD 8 cells. His research skills on Molecular cloning, Gene transfer, ELISA, Cell Culture, qRT-PCR, Multiplex immunoassays, Biochemistry, Assay Development.

Dr. Bhuvnesh K.Sharma
Dr. Bhuvnesh K.Sharma

is a Senior Director, ScyTek Labs, USA. His research focuses on Integrated Approach on Identifying and validating Translational / Predictive Cancer Biomarkers, Cancer Stem cells, Immunological markers to envisage Tumor recurrence/Therapeutic response or residual disease monitoring into the newer developmental strategies on Personalized Medicine in Human health care.

Dr. Livy Alex
Dr. Livy Alex

is a Technical Director, SLS Cell Cure Technologies Pvt Ltd, India. Her research focuses on Cardiovascular diseases, Breast cancer and prostate cancer. Her research skills were Handling of mammalian cells & related techniques, transient and stable transfections, experience with the Lonza system Bioassays, ELISA &immuno blotting, electrophoresis, studying extracellular enzymes and its activity.

Dr. Sanjeev K Anand
Dr. Sanjeev K Anand

is a Research Scientist at Elanco Animal Health, India. His research focuses on screening, assessment, research, development of very early technologies including antibiotics, immune modulators, biologicals, antivirals for therapeutic purposes and also responsible for finding new and innovative technologies which can not only help animals live long but also improve quality of life.